UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2562-2569

2015

Volltextzugriff (PDF)

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience

European journal of surgical oncology, 2013-04, Vol.39 (4), p.365-371

2013

Volltextzugriff (PDF)

Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial

International journal of radiation oncology, biology, physics, 2022-12, Vol.114 (5), p.849-855

2022

Volltextzugriff (PDF)

1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2023-10, Vol.34, p.S985-S985

2023

Volltextzugriff (PDF)

197P Malignant pleural effusion derived metastatic breast cancer cells as an ex vivo model for personalized drug response

ESMO open, 2024-05, Vol.9, p.103219, Article 103219

2024

Volltextzugriff (PDF)

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy

Clinical genitourinary cancer, 2024-04, Vol.22 (2), p.445-453.e1

2024

Volltextzugriff (PDF)

865P - Treatment outcomes of 3rd treatment in a real-world metastatic castration resistant prostate cancer (mCRPC) population: Results from the Dutch CAPRI-registry

Annals of oncology, 2019-10, Vol.30, p.v338-v339

2019

Volltextzugriff (PDF)

Treatment outcomes of 3rd treatment in a real-world metastatic castration resistant prostate cancer (mCRPC) population: Results from the Dutch CAPRI-registry

Annals of oncology, 2019-10, Vol.30, p.v338-v339

2019

Volltextzugriff (PDF)

869P - Real-world use of radium-223 for treatment of metastatic castration resistant-prostate cancer (mCRPC): Results from the Dutch CAPRI registry

Annals of oncology, 2019-10, Vol.30, p.v340-v340

2019

Volltextzugriff (PDF)

Real-world use of radium-223 for treatment of metastatic castration resistant-prostate cancer (mCRPC): Results from the Dutch CAPRI registry

Annals of oncology, 2019-10, Vol.30, p.v340

2019

Volltextzugriff (PDF)

Prognostic value of the clonal origin of lymph node metastases in prostate cancer

European urology open science (Online), 2021-11, Vol.33, p.S271-S272

2021

Volltextzugriff (PDF)

Role of local and/or metastasis-directed therapy in patients with hormone-sensitive M1a prostate cancer – a systematic review

European urology open science (Online), 2022-11, Vol.45, p.S158

2022

Volltextzugriff (PDF)

Basis for effective combination cancer chemotherapy with antimetabolites

Pharmacology & therapeutics (Oxford), 2000-08, Vol.87 (2), p.227-253

2000

Volltextzugriff (PDF)

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

Annals of oncology, 2009-01, Vol.20 (1), p.182-187

2009

Volltextzugriff (PDF)

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines

Biochemical pharmacology, 2004-02, Vol.67 (3), p.503-511

2004

Volltextzugriff (PDF)

58 Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e58-e58

2014

Volltextzugriff (PDF)

11 Neoadjuvante behandeling van locally advanced peniscarcinoom met taxanenbevattende combinatiechemotherapie

Tijdschrift voor urologie, 2013-05, Vol.3 (3), p.72-72

2013

Volltextzugriff (PDF)

11 Neoadjuvante behandeling van locally advanced peniscarcinoom met taxanenbevattende combinatiechemotherapie

Tijdschrift voor urologie, 2013, Vol.3 (3), p.72-72

2013

Volltextzugriff (PDF)

Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells

Urologia internationalis, 2010-01, Vol.84 (2), p.212-220

2010

Volltextzugriff (PDF)

The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent

Biochemical pharmacology, 2007-05, Vol.73 (10), p.1548-1557

2007

Volltextzugriff (PDF)

739 Neoadjuvant dose-dense MVAC for muscle invasive bladder cancer; efficacy and safety compared to the traditional MVAC regimen

European urology supplements : official journal of the European Association of Urology, 2015-04, Vol.14 (2), p.e739-e739

2015

Volltextzugriff (PDF)

787 Occult lymph node metastases in patients with muscle invasive bladder cancer: Incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e787-e787

2014

Volltextzugriff (PDF)

502 PIM1 EXPRESSION INCREASES CELL-CELL INTERACTION IN PROSTATE CANCER CELL LINES

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.246-246

2009

Volltextzugriff (PDF)

851 PIM1 AND ANDROGEN REGULATION THROUGH 17-BETA-HSD TYPE 2

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.270-270

2010

Volltextzugriff (PDF)

22 Neoadjuvante dose-dense MVAC voor spierinvasief blaascarcinoom

Tijdschrift voor urologie, 2014-10, Vol.4 (7), p.168-168

2014

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience

Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial

1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

197P Malignant pleural effusion derived metastatic breast cancer cells as an ex vivo model for personalized drug response

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy

865P - Treatment outcomes of 3rd treatment in a real-world metastatic castration resistant prostate cancer (mCRPC) population: Results from the Dutch CAPRI-registry

Treatment outcomes of 3rd treatment in a real-world metastatic castration resistant prostate cancer (mCRPC) population: Results from the Dutch CAPRI-registry

869P - Real-world use of radium-223 for treatment of metastatic castration resistant-prostate cancer (mCRPC): Results from the Dutch CAPRI registry

Real-world use of radium-223 for treatment of metastatic castration resistant-prostate cancer (mCRPC): Results from the Dutch CAPRI registry

Prognostic value of the clonal origin of lymph node metastases in prostate cancer

Role of local and/or metastasis-directed therapy in patients with hormone-sensitive M1a prostate cancer – a systematic review

Basis for effective combination cancer chemotherapy with antimetabolites

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines

58 Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer

11 Neoadjuvante behandeling van locally advanced peniscarcinoom met taxanenbevattende combinatiechemotherapie

11 Neoadjuvante behandeling van locally advanced peniscarcinoom met taxanenbevattende combinatiechemotherapie

Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells

The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent

739 Neoadjuvant dose-dense MVAC for muscle invasive bladder cancer; efficacy and safety compared to the traditional MVAC regimen

787 Occult lymph node metastases in patients with muscle invasive bladder cancer: Incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone

502 PIM1 EXPRESSION INCREASES CELL-CELL INTERACTION IN PROSTATE CANCER CELL LINES

851 PIM1 AND ANDROGEN REGULATION THROUGH 17-BETA-HSD TYPE 2

22 Neoadjuvante dose-dense MVAC voor spierinvasief blaascarcinoom

Suchergebnisse filtern